These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10864340)

  • 1. Geographic variation in patient surveillance after radical prostatectomy.
    Powell TM; Thompsen JP; Virgo KS; Johnson ET; Chan D; Colberg JW; Ornstein DK; Johnson FE
    Ann Surg Oncol; 2000 Jun; 7(5):339-45. PubMed ID: 10864340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma.
    Margenthaler JA; Meier JD; Virgo KS; Johnson DY; Goshima K; Chan D; Handler BS; Johnson FE
    Am J Surg; 2003 Aug; 186(2):194-200. PubMed ID: 12885617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current followup strategies after radical prostatectomy: a survey of American Urological Association urologists.
    Oh J; Colberg JW; Ornstein DK; Johnson ET; Chan D; Virgo KS; Johnson FE
    J Urol; 1999 Feb; 161(2):520-3. PubMed ID: 9915439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How tumor stage affects american urologists' surveillance strategies after prostate cancer surgery.
    Johnson FE; Virgo KS; Ornstein DK; Johnson ET; Chan D; Colberg JW
    Int J Oncol; 2000 Jun; 16(6):1221-5. PubMed ID: 10811999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The age of the urologist affects the postoperative care of prostate carcinoma patients.
    Tsai DY; Virgo KS; Colberg JW; Ornstein DK; Johnson ET; Chan D; Johnson FE
    Cancer; 1999 Oct; 86(7):1314-21. PubMed ID: 10506719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy.
    Trantham LC; Nielsen ME; Mobley LR; Wheeler SB; Carpenter WR; Biddle AK
    Cancer; 2013 Oct; 119(19):3523-30. PubMed ID: 23893821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer.
    Pruthi RS; Johnstone I; Tu IP; Stamey TA
    Urology; 1997 May; 49(5):737-42. PubMed ID: 9145980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variation in follow-up after rectal cancer surgery.
    Neils DM; Virgo KS; Longo WE; Ode K; Audisio RA; Shariff US; Papettas T; McGarry AE; Gammon SR; Johnson FE
    Int J Oncol; 2007 Mar; 30(3):735-42. PubMed ID: 17273776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of radical prostatectomy at a community hospital during the prostate specific antigen era.
    Smitt MC; Heltzel M
    Cancer; 1996 Mar; 77(5):928-33. PubMed ID: 8608486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of men whose radical prostatectomies failed: results of an international survey.
    Ornstein DK; Colberg JW; Virgo KS; Chan D; Johnson ET; Oh J; Johnson FE
    Urology; 1998 Dec; 52(6):1047-54. PubMed ID: 9836553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
    Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
    BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
    Soergel TM; Koch MO; Foster RS; Bihrle R; Wahle G; Gardner T; Jung SH
    J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
    Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
    Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
    Partin AW; Pearson JD; Landis PK; Carter HB; Pound CR; Clemens JQ; Epstein JI; Walsh PC
    Urology; 1994 May; 43(5):649-59. PubMed ID: 7513108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient surveillance after treatment for soft-tissue sarcoma.
    Johnson FE; Sakata K; Sarkar S; Audisio RA; Kraybill WG; Gibbs JF; Beitler AL; Virgo KS
    Int J Oncol; 2011 Jan; 38(1):233-9. PubMed ID: 21109945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical surveillance after surgery for prostate cancer].
    Guercio S; Terrone C; Scarpa RM
    Recenti Prog Med; 2003 Mar; 94(3):110-3. PubMed ID: 12677777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic variation in the conduct of patient surveillance after lung cancer surgery.
    Johnson FE; Naunheim KS; Coplin MA; Virgo KS
    J Clin Oncol; 1996 Nov; 14(11):2940-9. PubMed ID: 8918491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
    Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM
    J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.